Delivery Protein Peptide Drugs Cancer

We have collected information about Delivery Protein Peptide Drugs Cancer for you. Follow the links to find out details on Delivery Protein Peptide Drugs Cancer.


Delivery of Protein and Peptide Drugs in Cancer ...

    https://www.amazon.com/Delivery-Protein-Peptide-Drugs-Cancer/dp/1860946275
    Written by leading scientists in the field of delivery of protein and peptide drugs to tumors for cancer therapy, this important book provides a broad introduction to the field, with discussion by key experts on the physiological barriers for protein and peptide drugs in tumors, and the different approaches to stabilization of these drugs in biological surroundings, as well as their enhanced delivery to tumors and inside cancer …Author: Vladimir P. Torchilin

Transmembrane delivery of protein and peptide drugs by TAT ...

    https://www.sciencedirect.com/science/article/pii/S0169409X04002686
    The direct intracellular delivery of proteins, or active peptide domains, has, until recently, been difficult to achieve due primarily to the bioavailability barrier of the plasma membrane, which effectively prevents the uptake of macromolecules by limiting their passive entry.Author: Jehangir S. Wadia, Steven F. Dowdy

Recent Advances in Anti-cancer Protein/Peptide Delivery ...

    https://pubs.acs.org/doi/10.1021/acs.bioconjchem.8b00750
    Protein/peptide drugs possess unique advantages, such as high pharmacological potency, molecular specificity, multifunctionality, and low toxicity, and thus hold great potential for use in cancer therapy. In the past decades, great achievements have been made in protein delivery systems, which can protect cargo proteins against detrimental physiological environments and efficiently deliver ...Author: Xun Liu, Fan Wu, Yong Ji, Lichen Yin

Recent Advances in Anti-cancer Protein/Peptide Delivery.

    https://www.ncbi.nlm.nih.gov/pubmed/30428665
    Feb 20, 2019 · Recent Advances in Anti-cancer Protein/Peptide Delivery. Liu X(1), Wu F(1), Ji Y(2), Yin L(1). Author information: (1)Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Institute of Functional Nano and Soft Materials (FUNSOM), Collaborative Innovation Center of Suzhou Nano Science & Technology , Soochow University , Suzhou 215123 , China.Author: Xun Liu, Fan Wu, Yong Ji, Lichen Yin

Basic Strategies for PEGylation of Peptide and Protein Drugs

    https://www.worldscientific.com/doi/abs/10.1142/9781860948039_0004
    Basic Strategies for PEGylation of Peptide and Protein Drugs. Gianfranco Pasut, Margherita Morpurgo; ... Delivery of Protein and Peptide Drugs in Cancer. Enhanced Permeability and Retention (EPR) Effect and Tumor-Selective Delivery of Anticancer Drugs ... PEGylated Proteins in Immunotherapy of Cancer. James F. Eliason; Delivery of Protein and ...

Targeted drug delivery for cancer therapy: the other side ...

    https://jhoonline.biomedcentral.com/articles/10.1186/1756-8722-5-70
    Nov 09, 2012 · TMAs have mostly been used as naked antibodies but there is now high expectation of their employment in Targeted Drug Delivery (TDD), mainly because TDD systems can overcome many of the non-specific side effects associated with traditional cancer chemotherapy [5].Author: Michael A Firer, Gary Gellerman

Peptide-Based Cancer Therapeutics - Drug Development and ...

    https://drug-dev.com/peptide-based-cancer-therapeutics/
    Discovery of several protein/peptide receptors and tumor-related peptides and proteins is expected to create a new wave of more effective and selective anti-cancer drugs in the future, capturing the large share of the cancer therapeutic market.

Biologists' new peptide could fight many cancers

    https://phys.org/news/2018-01-biologists-peptide-cancers.html
    Jan 16, 2018 · MIT biologists have designed a new peptide that can disrupt a key protein that many types of cancers, including some forms of lymphoma, leukemia, and breast cancer, need to survive.

Cancer Treatment Using Peptides: Current Therapies and ...

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539351/
    Dec 20, 2012 · BN/GRP (bombesin/gastrin-releasing peptide) peptides were shown to bind selectively to the G-protein-coupled receptors on the cell surface, stimulating the growth of various malignancies in murine and human cancer models [134, 135]. Thus, it has been proposed that the secretion of BN/GRP by neuroendocrine cells might be responsible for the development and progression of prostate cancer …Author: Jyothi Thundimadathil

Evaluation of the use of therapeutic peptides for cancer ...

    https://jbiomedsci.biomedcentral.com/articles/10.1186/s12929-017-0328-x
    Mar 21, 2017 · ELP also enhanced the delivery of ELP-conjugated therapeutic peptides, which inhibited the attachment, spreading, migration and invasion of human ovarian cancer cells in cell culture and also inhibited the metastasis of ovarian cancer cells in vivo .Author: Susan Marqus, Elena Pirogova, Terrence J. Piva

Searching for Delivery Protein Peptide Drugs Cancer?

You can just click the links above. The data is collected for you.

Related Delivery Info